- Home
- TTNP vs TCRT Comparison
TTNP vs TCRT Comparison
Compare TTNP & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- TCRT
- Stock Information
- Founded
- TTNP 1991
- TCRT 1998
- Country
- TTNP United States
- TCRT United States
- Employees
- TTNP N/A
- TCRT N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- TCRT Health Care
- Exchange
- TTNP Nasdaq
- TCRT Nasdaq
- Market Cap
- TTNP 3.7M
- TCRT 3.8M
- IPO Year
- TTNP 1996
- TCRT N/A
- Fundamental
- Price
- TTNP $3.81
- TCRT $2.08
- Analyst Decision
- TTNP
- TCRT
- Analyst Count
- TTNP 0
- TCRT 0
- Target Price
- TTNP N/A
- TCRT N/A
- AVG Volume (30 Days)
- TTNP 8.5K
- TCRT 14.2K
- Earning Date
- TTNP 11-29-2024
- TCRT 11-14-2024
- Dividend Yield
- TTNP N/A
- TCRT N/A
- EPS Growth
- TTNP N/A
- TCRT N/A
- EPS
- TTNP N/A
- TCRT N/A
- Revenue
- TTNP $3,000.00
- TCRT $7,000.00
- Revenue This Year
- TTNP N/A
- TCRT N/A
- Revenue Next Year
- TTNP N/A
- TCRT N/A
- P/E Ratio
- TTNP N/A
- TCRT N/A
- Revenue Growth
- TTNP N/A
- TCRT N/A
- 52 Week Low
- TTNP $3.57
- TCRT $1.95
- 52 Week High
- TTNP $14.80
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- TTNP 34.23
- TCRT 44.32
- Support Level
- TTNP $3.77
- TCRT $2.00
- Resistance Level
- TTNP $4.66
- TCRT $2.86
- Average True Range (ATR)
- TTNP 0.28
- TCRT 0.17
- MACD
- TTNP 0.04
- TCRT 0.05
- Stochastic Oscillator
- TTNP 3.93
- TCRT 14.29
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.